FDA clears HealthMyne's new analytics software

Imaging analytics software developer HealthMyne has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new analytics software.

The software is designed to provide radiologists with workflow efficiencies related to oncology cases, as well as advanced decision support. New image characterization and tracking features are included in the quantitative imaging dashboard, which includes time-sequenced information from Epic electronic health records.

The analytics software also offers tracking of nodules or tumors over multiple, spatially registered imaging studies, which can reveal information about whether the structure is growing, shrinking, or stable.

HealthMyne will be exhibiting at the Society of Thoracic Radiology (STR) annual meeting being held in Scottsdale, AZ, from March 13-16.

Page 1 of 603
Next Page